Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-03-01 @ 6:02 AM
Study NCT ID:
NCT01885260
Status:
COMPLETED
Last Update Posted:
2016-07-04
First Post:
2013-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-13
First Submit QC Date:
None
Study First Post Date:
2013-06-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-06-16
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-06-30
Last Update Post Date:
2016-07-04
Last Update Post Date Type:
ESTIMATED